Fate Therapeutics, Inc.— Sankey Diagram

Annual mode · period ending 2025-12-31 · SEC EDGAR

FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$319M
↓-27.6% -$122Mvs FY2024
Total Liabilities
$36M
↓-6.4% -$2Mvs FY2024
Equity
$207M
↓-35.0% -$112Mvs FY2024
Cash
$47M
↑+29.3% +$11Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the annual mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2025FY2024
Total Assets$319M$441M
Current Assets$209M$292M
Cash$47M$36M
ST Investments$157M$243M
Receivables$916K$4M
Inventory$0$0
Other Current$4M$9M
Non-Current Assets$110M$149M
PPE$57M$64M
Goodwill$0$0
Intangibles$0$0
Investments$1M$28M
Other Non-Current$52M$57M
Total Liab+Eq$207M$319M
Current Liab.$36M$39M
Accounts Payable$3M$9M
Short-Term Debt$0$0
Deferred Revenue$381K$393K
Other CL$33M$29M
Non-Current Liab.$0$0
Long-Term Debt$0$0
Other LT Liab.$0$0
Equity$207M$319M
Retained Earnings$1.53B$1.40B
Other Equity$0$0

QuarterCharts · SEC EDGAR data · FATE · Comparing FY2025 vs FY2024